Reaction

Respiratory Syncytial Virus Test Positive reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 696 reports · 21 co-occurring drugs

As of the last recalculation, Respiratory Syncytial Virus Test Positive appears in 696 FAERS reports alongside 21 co-occurring drug terms. The strongest observed disproportionality signal is PALIVIZUMAB (PRR 1,081.0).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Palivizumab3091,081.01,103.3
Promethazine Hydrochloride5799.8100.1
Insulin Glargine-Yfgn6089.789.9
Anastrozole Tablets5278.278.4
Esomeprazole Magnesium Capsule, Delayed Release2962.362.4
Esomeprazole Magnesium Delayed Release Capsules2962.362.4
Esomeprazole Magnesium Dihydrate2962.162.2
Anastrozole6356.356.4
Rosuvastatin Calcium4449.849.9
Loratadine Oral7047.347.3
Esomeprazole6433.933.9
Apixaban6330.930.9
Metformin Hydrochloride Tablets5430.430.5
Metformin Hydrochloride Extended-Release Tablets5430.430.5
Metformin Hydrochloride Tablet5430.430.5
Metformin Hydrochloride5429.529.5
Mercaptopurine1526.426.4
Montelukast6625.925.9
Loratadine7121.921.9
Pegaspargase819.819.8
Vincristine Sulfate1414.614.6

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.